103 related articles for article (PubMed ID: 1399954)
21. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
22. A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas.
Bébéar C; Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():59-62. PubMed ID: 9511064
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp.
Edelstein PH; Edelstein MA
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):49-52. PubMed ID: 10744367
[TBL] [Abstract][Full Text] [Related]
24. Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila.
Dowling JN; McDevitt DA; Pasculle AW
Antimicrob Agents Chemother; 1985 Feb; 27(2):272-4. PubMed ID: 3985605
[TBL] [Abstract][Full Text] [Related]
25. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
Reznicek M; Bale M; Pfaller M
Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
[TBL] [Abstract][Full Text] [Related]
26. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species.
Johnson DM; Erwin ME; Barrett MS; Gooding BB; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):751-5. PubMed ID: 1425738
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Edelstein PH; Gaudet EA; Edelstein MA
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
[TBL] [Abstract][Full Text] [Related]
29. The in-vitro activity of RP 59500 against gram-positive cocci.
Goto S; Miyazaki S; Kaneko Y
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():25-8. PubMed ID: 1399947
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Legionella species to antimicrobial agents.
Chen SC; Paul ML; Gilbert GL
Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
[TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
Pechère JC
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
[TBL] [Abstract][Full Text] [Related]
32. Persistence in serum and lungs of guinea pigs of erythromycin, gentamicin, chloramphenicol and rifampicin and their in-vitro activities against Legionella pneumophila.
Gibson DH; Fitzgeorge RB
J Antimicrob Chemother; 1983 Sep; 12(3):235-44. PubMed ID: 6630106
[TBL] [Abstract][Full Text] [Related]
33. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
[TBL] [Abstract][Full Text] [Related]
36. The activity of imipenem on Legionella pneumophila, with a note on the treatment of two cases.
Farrell ID; Barker J; Chiodini PL; Hutchison JG; Geddes AM
J Antimicrob Chemother; 1985 Jul; 16(1):61-5. PubMed ID: 3862660
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
[TBL] [Abstract][Full Text] [Related]
38. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
39. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
Leclercq R; Nantas L; Soussy CJ; Duval J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
[TBL] [Abstract][Full Text] [Related]
40. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).
Dowling JN; Weyant RS; Pasculle AW
Antimicrob Agents Chemother; 1982 Aug; 22(2):272-6. PubMed ID: 6927637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]